patient
TP53-Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm: Distinct Mutation Leads to Poorer Prognosis
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia
Dear Editor,
Real-World Outcomes of Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms
Abstract
2025 Rockville Patient and Family Conference Session: PNH
In this recording, Dr. Bhumika Patel discusses what is new in PNH and current treatment options available to patients.
2025 Patient and Family Conference Session: MDS and MPNs
In this recording, Dr. Catherine Lai discusses MDS and how patients can also be diagnosed with MPN's. Her presentation discusses the treatment options available to patients and resources.
2025 Rockville Patient and Family Conference: Debra's Story - Aplastic Anemia
2025 Rockville Patient and Family Conference: Low Risk MDS
In this recording, Dr. Ball Brian discusses low risk MDS and current treatment options.
2025 Rockville Patient and Family Conference Session: MDS and Transplant
In this recording, Dr. Parveen Shiraz discusses transplant for MDS and potentials complications such as GVHD and treatment options.